Carole Coze

4.3k total citations
93 papers, 2.4k citations indexed

About

Carole Coze is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Carole Coze has authored 93 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Neurology, 30 papers in Molecular Biology and 27 papers in Oncology. Recurrent topics in Carole Coze's work include Neuroblastoma Research and Treatments (46 papers), Cancer therapeutics and mechanisms (21 papers) and Cancer, Hypoxia, and Metabolism (13 papers). Carole Coze is often cited by papers focused on Neuroblastoma Research and Treatments (46 papers), Cancer therapeutics and mechanisms (21 papers) and Cancer, Hypoxia, and Metabolism (13 papers). Carole Coze collaborates with scholars based in France, Ivory Coast and United States. Carole Coze's co-authors include Jean Michon, Olivier Hartmann, Didier Frappaz, Dominique Plantaz, Christophe Bergeron, Pascal Chastagner, Thierry Philip, Olivier Delattre, Éric Bouffet and Nicolás André and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Carole Coze

90 papers receiving 2.3k citations

Peers

Countries citing papers authored by Carole Coze

Since Specialization

Citations

This map shows the geographic impact of Carole Coze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carole Coze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carole Coze more than expected).

Fields of papers citing papers by Carole Coze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carole Coze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carole Coze. The network helps show where Carole Coze may publish in the future.

Co-authorship network of co-authors of Carole Coze

This figure shows the co-authorship network connecting the top 25 collaborators of Carole Coze. A scholar is included among the top collaborators of Carole Coze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carole Coze. Carole Coze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Transformative Decade: An Evaluation of the Francophone African Group of Pediatric Oncology’s Training Program (2014–2024) 2024 ·Journal of Cancer Education ·(unknown), (unknown), Carole Coze, Catherine Patte, Jaques van Heerden, Hélène Martelli, Mhamed Harif, Laila Hessissen	2
2	Development and Validation of a Prediction Model of Overall Survival in High-Risk Neuroblastoma Using Mechanistic Modeling of Metastasis 2021 ·JCO Clinical Cancer Informatics ·Sébastien Benzekry, (unknown), Carole Coze, L. Tessonnier, Nicolás André	11
3	BNT162b2 mRNA Covid-19 Vaccine in AYA with cancer: a monocentric experience 2021 ·European Journal of Cancer ·(unknown), Läétitia Ninove, (unknown), Angélique Rome, Carole Coze, Arnauld Verschuur, (unknown), Nicolás André	2
4	Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies 2021 ·Hepatology International ·(unknown), (unknown), Sophie Taque, (unknown), (unknown), Véronique Laithier, (unknown), Hélène Sudour‐Bonnange, Cécile Faure‐Conter, Carole Coze, Isabelle Aerts, (unknown), Catherine Paillard, Sophie Branchereau, Laurence Brugières, Brice Fresneau	7
5	Impact d’un programme de diagnostic précoce des cancers de l’enfant à Abidjan ? 2021 ·Bulletin du Cancer ·(unknown), Carole Coze, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
6	Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experience 2020 ·Pediatric Blood & Cancer ·(unknown), Gaëlle Bougeard, Marie Karanian, (unknown), Cécile Boulanger, Hélène Boutroux, Claire Briandet, Christine Chevreau, Nadège Corradini, Carole Coze, Anne Sophie Defachelles, (unknown), Daniel Orbach, Christophe Piguet, Jean‐Yves Scoazec, Cécile Verite, Marjolaine Willems, Thierry Frébourg, Véronique Minard‐Colin, Laurence Brugières	18
7	Detection of tumor ALK status in neuroblastoma patients using peripheral blood 2015 ·Cancer Medicine ·Valérie Combaret, Isabelle Iacono, Angela Bellini, (unknown), Virginie Bernard, Aurélien Marabelle, Carole Coze, Gaëlle Pierron, Eve Lapouble, Gudrun Schleiermacher, Jean‐Yves Blay	55
8	A dose‐intensive approach (NB96) for induction therapy utilizing sequential high‐dose chemotherapy and stem cell rescue in high‐risk neuroblastoma in children over 1 year of age 2011 ·Pediatric Blood & Cancer ·(unknown), Caroline Munzer, Dominique Valteau‐Couanet, (unknown), Carole Coze, Pascal Chastagner, Hervé Rubie, François Deméocq, Jean‐Louis Stephan, Olivier Hartmann, Yves Pérel	5
9	Retrospective comparison of neutropenia in children with ewing sarcoma treated with chemotherapy and granulocyte colony-stimulating factor (G-CSF) or pegylated G-CSF 2009 ·Clinical Therapeutics ·(unknown), Jean Gaudart, Angélique Rome, Carole Coze, Jean Claude Gentet, Laëtitia Padovani, Bruno Lacarelle, Nicolás André	7
10	FDG PET and Evaluation of Posttherapeutic Residual Tumors in Pediatric Oncology: Preliminary Experience 2008 ·Journal of Pediatric Hematology/Oncology ·Nicolás André, Alexandre Fabre, C. Colavolpe, (unknown), Jean Gaudart, Carole Coze, (unknown), Jean Claude Gentet, Eric Guedj, Gérard Michel, O. Mundler	3
11	Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology 2006 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Olivier Hartmann, Jean Michon, Ross Pinkerton, Carole Coze, Jean Louis Stéphan, (unknown), Dominique Valteau‐Couanet, Christophe Bergeron, Thierry Philip, C. Carrié	60
12	Le pronostic du neuroblastome de l'enfant. Méthodes d'étude et utilisation en pratique clinique 2004 ·Archives de Pédiatrie ·Yves Pérel, Dominique Valteau‐Couanet, Jean Michon, F. Lavrand, Carole Coze, Christophe Bergeron, (unknown), Dominique Plantaz, Pascal Chastagner, Frédéric Bernard, Caroline Thomas, H Rubie	13
13	The LMCE5 unselected cohort of 25 children consecutively diagnosed with untreated stage 4 neuroblastoma over 1 year at diagnosis 2002 ·British Journal of Cancer ·Didier Frappaz, David Pérol, Jean Michon, Claire Berger, Carole Coze, J Bernard, Jean‐Michel Zucker, Thierry Philip	6
14	Localised and unresectable neuroblastoma in infants: Excellent outcome with primary chemotherapy 2001 ·Medical and Pediatric Oncology ·H Rubie, Dominique Plantaz, Carole Coze, Jean Michon, Didier Frappaz, M.C. Baranzelli, Pascal Chastagner, (unknown), (unknown)	20
15	Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry. 1998 ·Journal of Clinical Oncology ·Ruth Ladenstein, Thierry Philip, Christine Lasset, Olivier Hartmann, Alberto Garaventa, Ross Pinkerton, Jean Michon, Jon Pritchard, Thomas Klingebiel, Bernhard Kremens, Andrew D.J. Pearson, Carole Coze, Paolo Paolucci, Didier Frappaz, Helmut Gadner, Franck Chauvin	127
16	Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide 1998 ·British Journal of Cancer ·(unknown), H Rubie, Jean Michon, Dominique Plantaz, (unknown), Carole Coze, Didier Frappaz, Pascal Chastagner, (unknown), Françoise Méchinaud, Patrick Boutard, P Lutz, Yves Pérel, G Leverger, L. de Lumley, Frédéric Millot, (unknown), Geneviève Margueritte, Olivier Hartmann	25
17	N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique. 1997 ·Journal of Clinical Oncology ·H Rubie, Olivier Hartmann, Jean Michon, Didier Frappaz, Carole Coze, Pascal Chastagner, M.C. Baranzelli, Dominique Plantaz, Hervé Avet‐Loiseau, Jean Bénard, Olivier Delattre, M Favrot, (unknown), Antoine Thyss, Yves Pérel, Christophe Bergeron, (unknown), J.P. Vannier, J Lemerle, D. Sommelet	148
18	The impact of megatherapy on response and survival in high-risk Ewing's sarcoma. A report of the EBMT solid tumor registry 1992 ·Bone Marrow Transplantation ·Ruth Ladenstein, Christine Lasset, Pierre Biron, Jean Michon, Helmut Gadner, Ross Pinkerton, Stefan Burdach, Núria Pardo, Alberto Garaventa, Carole Coze, O Hartmann	3
19	Expression of leucocyte adhesion molecules on 66 clinical neuroblastoma specimens 1991 ·International Journal of Cancer ·Marie Favrot, Valérie Combaret, Evelyne Goillot, Éric Tabone, Éric Bouffet, (unknown), R Bouvier, Carole Coze, J Michon, Thierry Philip	33
20	A phase-II study of adoptive immunotherapy with continuous infusion of interleukin-2 in children with advanced neuroblastoma. A report on 11 cases 1989 ·Cancer Treatment Reviews ·M Favrot, D. Floret, Jean Michon, Sylvie Négrier, Éric Bouffet, Carole Coze, M Gaspard, Pierre Cochat, Philippe Thiesse, G. Andreu, J Costil, Jean‐Michel Zucker, Jean‐Louis Bernard, Wolf H. Fridman, Claire Mathiot, (unknown), C.R. Franks, (unknown), I Philip, Thierry Philip	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact